Author | Carlos Arteaga | OncLive

Author | Carlos Arteaga

Articles

Dr. Arteaga on PI3K Pathway Inhibitors

January 06, 2015

Video

Carlos Arteaga, MD, assistant director, Clinical Research, director, Breast Cancer program, Vanderbilt-Ingram Cancer Center, discusses the PI3K pathway and the role of therapeutic inhibitors in reducing the progression of breast cancer.

x